Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.5757
-0.0244 (-4.07%)
Aug 10, 2026, 11:58 AM EDT - Market open
Evogene Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -21.04 | -13.5 | -14.82 | -21.97 | -29.84 | -30.45 |
Depreciation & Amortization | 1.04 | 1.14 | 1.38 | 1.3 | 2.58 | 2.23 |
Stock-Based Compensation | 0.41 | 0.65 | 1.24 | 1.11 | 1.19 | 2.61 |
Other Adjustments | 3.74 | -0.55 | -4.89 | -1.74 | 3.17 | -0.77 |
Change in Receivables | 2.23 | 0.67 | -0.63 | -0.01 | -0.07 | -0.06 |
Changes in Inventories | -0.54 | -1.02 | -1.28 | 0.49 | -0.47 | -0.09 |
Changes in Accounts Payable | -0.07 | -0.26 | -0.63 | 0.76 | -0.47 | 0.63 |
Changes in Accrued Expenses | -0.47 | -0.76 | -0.55 | 0.53 | -0.68 | 0.13 |
Changes in Unearned Revenue | -0.21 | -0.36 | -0.56 | -0.29 | -0.15 | 0.13 |
Changes in Other Operating Activities | -0.55 | 0.48 | 1.03 | -1.76 | 1.07 | 0.93 |
Operating Cash Flow | -11.27 | -13.5 | -19.7 | -21.58 | -23.68 | -24.72 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.02 | -0.14 | -0.63 | -0.58 | -1.17 | -0.85 |
Sale of Property, Plant & Equipment | 0.1 | 0.08 | 0.01 | 0.03 | - | - |
Purchases of Investments | - | -0 | -17.15 | -19.7 | -0.91 | -23.11 |
Proceeds from Sale of Investments | -2.2 | - | 27.34 | 15.92 | 15.36 | 3.4 |
Other Investing Activities | 17.81 | 17.8 | 0.05 | -0.21 | - | - |
Investing Cash Flow | 15.7 | 17.74 | 9.62 | -4.54 | 13.27 | -20.57 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Issuance of Common Stock | 7.57 | 4.28 | 5.62 | 8.45 | 0.03 | 30.07 |
Net Common Stock Issued (Repurchased) | 7.57 | 4.28 | 5.62 | 8.45 | 0.03 | 30.07 |
Other Financing Activities | -10.94 | -10.89 | -0.97 | 9.7 | 9.32 | 0.21 |
Financing Cash Flow | -3.45 | -6.6 | 4.66 | 18.15 | 9.34 | 30.28 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.04 | 0.02 | -0.05 | -0.25 | -2.28 | 1.1 |
Net Cash Flow | 1.02 | -2.35 | -5.47 | -8.21 | -3.35 | -13.9 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.29 | -13.64 | -20.33 | -22.15 | -24.85 | -25.56 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -612.26% | -353.93% | -364.46% | -742.92% | -1483.52% | -2748.71% |
Free Cash Flow Per Share | -1.31 | -1.73 | -3.57 | -4.83 | -6.00 | -6.32 |
Levered Free Cash Flow | -12.58 | -9.39 | -17.72 | -23.43 | -25.93 | -24.69 |
Unlevered Free Cash Flow | -14.97 | -14.94 | -20.05 | -21.8 | -26.32 | -27.86 |